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Abstract
Background: Male-factor infertility presents a vexing problem for many reproductively active couples. Many studies
have focused on abnormal sperm parameters. Recent advances in proteomic techniques, especially in mass
spectrometry, have aided in the study of sperm and more specifically, sperm proteins. The aim of this study was to
review the current literature on the various proteomic techniques, and their usefulness in diagnosing sperm
dysfunction and potential applications in the clinical setting.
Methods: Review of PubMed database. Key words: spermatozoa, proteomics, protein, proteome, 2D-PAGE, mass
spectrometry.
Results: Recently employed proteomic methods, such as two-dimensional polyacrylamide gel electrophoresis, mass
spectrometry, and differential in gel electrophoresis, have identified numerous sperm-specific proteins. They also
have provided a further understanding of protein function involved in sperm processes and for the differentiation
between normal and abnormal states. In addition, studies on the sperm proteome have demonstrated the
importance of post-translational modifications, and their ability to bring about physiological changes in sperm
function. No longer do researchers believe that in order for them to elucidate the biochemical functions of genes,
mere knowledge of the human genome sequence is sufficient. Moreover, a greater understanding of the
physiological function of every protein in the tissue-specific proteome is essential in order to unravel the biological
display of the human genome.
Conclusion: Recent advances in proteomic techniques have provided insight into sperm function and dysfunction.
Several multidimensional separation techniques can be utilized to identify and characterize spermatozoa. Future
developments in bioinformatics can further assist researchers in understanding the vast amount of data collected
in proteomic studies. Moreover, such advances in proteomics may help to decipher metabolites which can act as
biomarkers in the detection of sperm impairments and to potentially develop treatment for infertile couples.
Further comprehensive studies on sperm-specific proteome, mechanisms of protein function and its proteolytic
regulation, biomarkers and functional pathways, such as oxidative-stress induced mechanisms, will provide better
insight into physiological functions of the spermatozoa. Large-scale proteomic studies using purified protein assays
will eventually lead to the development of novel biomarkers that may allow for detection of disease states, genetic
abnormalities, and risk factors for male infertility. Ultimately, these biomarkers will allow for a better diagnosis of
sperm dysfunction and aid in drug development.
Background
As infertility affects nearly 15% of all couples of reproduc-
tive age [1,2], and family sizes continue to shrink, concerns
about the reproductive potential of future generations are
growing. Although infertility was believed to originate
from female abnormalities, recent discoveries have
revealed that as many as 50% of cases stem from male-fac-
tor defects, with no identifiable cause in 25% of infertile
men [3,4]. Male infertility presents an interesting, yet vex-
ing, problem for men all over the world. Suboptimal
sperm quality due to abnormal parameters–motility,
morphology, concentration, DNA fragmentation, and
genetic composition–has been linked to this issue. Never-
theless, our current understanding of the spermatozoa and
its pathological and physiological effects are lacking and
vaguely defined.
The study of cellular components on a molecular level
offers much hope in deciphering the metabolic pathways
essential for the diagnosis of male infertility. Advances
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in spermatozoa research-including those in the field of
proteomics-have allowed for enhanced characterization
and identification of both the structural and functional
proteins of spermatozoa. However, these findings remain
limited. Because the spermatozoon is an extremely com-
plex and highly accessible cell, it is remarkably suitable
for proteomic analysis [5]. Moreover, because the sperm
cell is responsible for transporting the paternal genome
to the oocyte, examining its genetic composition may
provide beneficial insight into ensuing disorders in
offspring.
Recently employed proteomic techniques, such as 2D
polyacrylamide gel electrophoresis (2D-PAGE), mass
spectrometry (MS), and differential in gel electrophoresis
(DIGE), have allowed for the identification of numerous
sperm-specific proteins. These approaches have provided
a greater understanding of protein function involved in
sperm processes such as motility, capacitation, acrosome
reaction, and fertilization. Studies of the sperm proteome
have demonstrated how post-translational modifications,
such as phosphorylation, glycosylation, proteolytic clea-
vages and mutations, bring about the physiological
changes in spermatozoa function. Furthermore, proteo-
mic analysis has allowed for the study of spermatozoa in
different functional states–immature versus mature,
uncapacitated versus capacitated, normal versus defec-
tive, and low sperm count versus high sperm count–all
of which impact the male reproductive potential.
In this review, various proteomic techniques and their
usefulness in diagnosing sperm dysfunction, as well as
the possible application in the clinical setting will be
examined.
Understanding the need for proteomic research
The human genome was first sequenced 10 years ago
[6]. Since then, a vast amount of DNA sequences,
including the diploid genome sequence of a human,
have been made available in public databases [7]. Inves-
tigators are now beginning to understand that the pro-
mise of molecular medicine as a cure for genetic
diseases was over emphasized, and that merely knowing
the human genome sequences is not enough to eluci-
date the biochemical functions of genes. To unravel the
biological display of the human genome, there must be
greater understanding of the physiological function of
every protein in the tissue-specific proteome. The
genetic basis of human disease is much more complex
than it was previously thought as a multitude of meta-
bolic and regulatory pathways, post-translational modifi-
cations and complex protein-protein interactions play a
major role [8]. Therefore organ- and tissue-specific pro-
teomic studies will contribute directly to understand the
fundamentals of spermatozoa and its physiological func-
tion in male fertility.
Further comprehensive studies on sperm-specific pro-
teome, mechanisms of protein function and its proteoly-
tic regulation, biomarkers and functional pathways, such
as oxidative-stress induced mechanisms, will provide
better insight into physiological functions of the sperma-
tozoa. Large-scale proteomic studies using purified pro-
tein assays will eventually lead to the development of
novel biomarkers that may allow for detection of disease
states, genetic abnormalities, and risk factors for male
infertility. Ultimately, these biomarkers will allow for a
better diagnosis of sperm dysfunction and aid in drug
development.
Proteomics–a brief overview
During the 1980s there were several new advances in
molecular biology such as gene cloning, sequencing, and
expression analysis. This transpired to the links between
observed activity and protein function and its encoded
gene to give way to protein chemistry. These novel
approaches of identifying and characterizing proteins by
means of both qualitative and quantitative analysis
became known as proteomics. Scientists no longer only
focused on the genomes of an organism, but rather
turned their attention equally towards the structure of
proteins and the functional interactions between the
proteins.
As research soared in the mid-1990s, scientists
attempted to discover a link between the genome
expressing the proteins of a living cell and advances in
new high-throughput techniques to aid in the process.
This interest allowed for the development of successful
sequencing analysis, reversible approaches that focused
on phenotype instead of genotype, and gene sequencing
databases. It was believed that if a link between the gen-
otype and phenotype could be made, it would be plausi-
ble to examine all of an organism’s proteins instead of
concentrating on one to further understand their struc-
ture, function and their biochemical role in the body.
Proteomic approaches are generally now utilized for
protein profiling, comparing the protein expression in
specific organs and tissues, localizing and identifying
post-translational modifications, and studying protein-
protein interactions. New fractionation and labeling
techniques have further enhanced protein identification
of some of the least abundant proteins. It is these less
prevalent proteins that have major impacts on biological
systems and may be potentially valuable in clinical diag-
nosis and prescribing treatment.
Although the total number of human protein products
has been estimated to be approximately one million,
and comparison of different proteomes is possible via
analysis of post-translational modifications, there still
remain several limitations and hurdles [9-11]. The pro-
teomes of mammalian cells, tissues, and bodily fluids,
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and their readily active concentrations and local envir-
onment are so intricate that even new techniques are
unable to make fully accurate measurements. The large
quantity of data that has been obtained thus far places
further challenges on data processing and analysis.
Nevertheless, while researchers now face additional lim-
itations in fully sequencing proteins and peptides due to
the complex nature and physiological processes of the
proteome, extensive advancements in technology, meth-
ods of analysis and ways to overcome these matters
hold for a promising future.
The basic process
In order to understand how human seminal proteins
can be identified and characterized, the basic process of
proteomic analysis will be described in brief. After the
collection and liquefaction of a neat semen sample, it
can be used as is or further processed (e.g. separating
into mature and immature sperm populations by density
gradient centrifugation). The recovered spermatozoa can
be extracted and purified, after which the protein con-
centration can be determined in order to allow for equal
protein-loading gradient on electrophoretic gels. Because
proteins differ from each other in terms of their charge
and mass, they can be separated using gel electrophor-
esis methods, such as one-dimensional sodium dodecyl
sulfate polyacrylamide gel electrophoresis (1D SDS-
PAGE), two-dimensional sodium dodecyl sulfate polya-
crylamide gel electrophoresis (2D SDS-PAGE) or DIGE.
Various stains (e.g. Coomassie Brilliant Blue and Sil-
ver) are used to identify the positions of individual pro-
teins within the gel, which appear as spots or smudges.
These in turn can be excised and analyzed by MS. Pep-
tides generated by in-gel digestion of the proteins in the
1D/2D SDS-PAGE gels and those digested by trypsin in
DIGE samples can be extracted and subsequently puri-
fied by liquid chromatography. The extracted peptides
can be directly analyzed by matrix assisted laser deso-
rption ionization-time of flight (MALDI-TOF-TOF) or
liquid chromatography - mass spectrometry/mass spec-
trometry (LC-MS/MS). These purified peptides can then
be subjected to MS, or tandem MS (MS/MS), to identify
the protein by peptide mass mapping as well as by
sequencing the peptides by further fragmentation char-
acteristic mass-to-charge ratio (m/z) of ions that is
resembled in a specific mass spectrum. Finally, the data
obtained can be analyzed, and the amino acid sequence
can be submitted into a database to search for matching
peptide sequences and thereby identifying the protein(s)
that are most likely present.
Techniques
The initial purpose of proteomics was simply to analyze
a proteome–the protein compliment expressed by a
genome–using techniques such as two-dimensional gel
electrophoresis (2D-E) and protein staining followed by
in-gel digestion, peptide extraction and identification of
peptide protein spots using MALDI-TOF-TOF or MS/
MS [12-16]. The highly dynamic proteome depends on
environmental conditions as the proteins’ activity and
their abundance vary at different physiological states
and locations of the cell or tissue. Over time, the field
expanded into profiling functional and structural proteo-
mics, specifically aiming to identify and characterize a
complete set of proteins present in a cell, organ, or
organism [12]. In order to accommodate this higher
level of focus, a wide range of techniques has been
employed.
Profiling proteomics attempts to differentiate proteins
expressed between two samples (cells or organisms)
while exemplifying the variations in expression levels of
two different states [17]. Distinguishing alternations in
the proteome during normal or stressed conditions may
help elucidate the processes of signaling pathways in cer-
tain disease states. On the other hand, functional proteo-
mics is employed when searching for protein functions
on post-translationally modified proteins, which are
essential in understanding the functions and role of pro-
tein in a living organism [17]. Finally, structural proteo-
mics focuses on the tertiary structure of proteins and
their complexes with other small molecules and proteins
[17]. Understanding how proteins interact with their cor-
responding binding substrates may help uncover the
mechanistic pathways these molecules undergo and sub-
sequently further improve our knowledge of the pro-
teome and its relation to human life adversities.
Many researchers have begun to note the abundance
of proteins and their functions in humans. The human
genome harbors 31000 protein-encoding genes [18].
New advances in proteomics have contributed to the
most recent knowledge and understanding of how sper-
matozoa function and acquire the ability to fertilize [19].
Post-translational modifications (PTM) are essential for
the functionality of spermatozoa, both during the
maturation of the cells in the epididymis and post-ejacu-
latory capacitation in the female reproductive tract (See
Figure 1) [19]. The modifications that are made via gly-
cosylation, methylation, or phosphorylation are capable
of altering the functional properties of spermatozoa and
seminal plasma proteins that consequently result in
abnormal and difficult to detect effects. Therefore,
understanding the function of each protein requires
information not only on quantitative levels of gene
expression at both the mRNA (transcriptome) and pro-
tein (proteome) levels but also on quantitative levels of
proteolytic activity and eventually information on endo-
genous protein substrates and products along with their
physiological significance.
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As the field of proteomics continues to grow, advances
in technology and techniques have allowed for enhanced
protein separation, fractionation, purification, detection,
isolation, identification and characterization. Most of the
recent proteomic studies have focused on improving the
resolution of separation and the identification of every
protein by gel electrophoresis and MS analysis [15]. In
addition, peak and multidimensional separations have
given us further insight into a protein sample while also
elevating the sensitivity for sample analysis [20-23].
Nevertheless, separation of a complex mixture of protein
and peptides still remains one of the most difficult chal-
lenges. If it is possible to quantitatively identify uniquely
expressed proteins in a disease state (as a biomarker)
then a link to possible disease states can be established
and potential therapeutic treatments may be discovered.
The following subsections will give an overview of some
of the most commonly used proteomic techniques that
have allowed for the extraordinary advances in the field,
particularly in sperm cell biology (See Figure 2).
Gel electrophoresis
Gel electrophoresis is a common gel-based technique
that has played a revolutionary role in the field of pro-
tein separation studies. This method separates deoxyri-
bonucleic acid (DNA), ribonucleic acid (RNA), and
proteins from complex mixtures, allowing for the detec-
tion and approximate quantification of proteins. In gen-
eral, electrophoresis utilizes an applied electromotive
force to a cross-linked polymer gel matrix that can limit
the motion of molecules based on their mass and
charge. Since 1D gel electrophoresis methods have lim-
ited resolving power to separate complex mixtures of
proteins, particularly low-abundance proteins, multidi-
mensional approaches have been currently employed to
overcome these challenges.
Two-dimensional gel electrophoresis
2D-E is a widely accepted electrophoresis method that
analyzes qualitative and quantitative characterization of
proteins and changes in the proteome at high resolution
on a large scale. It can thus serve as an initial screening
method to acquire hypotheses and establish future
explorative directions. The proteins on the gel may
represent a compliment of active proteins in a particular
tissue or cell at any given time.
In addition, the resolving power and sensitivity as well
as the low equipment cost are attractive to researchers.
However, heterogeneities in different gels, the electric
fields, pH gradients, and thermal fluctuations are only a
few factors that may influence enzymatic activity,
thereby making protein verification difficult. Therefore,
much focus has been given to improving methods to
overcome these variations and detect low-abundance
protein modifications, which are the primary proteins of
interest. This would give us a better understanding of
protein structure and function as well as provide a plau-
sible diagnostic tool.
2D-PAGE examines proteins based on their isoelectric
point (pI) via isoelectric focusing separation in the first
dimension followed by separation in the second dimen-
sion based on molecular mass using sodium dodecyl sul-
fate polyacrylamide gel electrophoresis (SDS-PAGE).
SDS-PAGE specifically separates proteins according to
their electrophoretic mobility–a function of polypeptide
Figure 1 Cellular changes occurring during spermatogenesis.
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chain length or molecular mass. Polyacrylamide provides
a support matrix through which proteins can migrate.
Since 2D-PAGE is not sensitive enough to detect rare or
low-abundance proteins, many proteins will not be
resolved, and further splitting of the sample into differ-
ent subcellular fractions may be necessary to reduce the
complexity of protein mixtures prior to 2D-PAGE
analysis.
Proteins have varying charges, shapes and sizes and
thus travel at different rates through the gel. To address
this problem, proteins are usually denatured in a deter-
gent, such as SDS, which coats the protein with a nega-
tive charge. In turn, the charge of the protein no longer
becomes a contributing factor to its movement on the
gel, and protein size becomes the main determinant. In
other words, the larger the protein, the more restricted
Figure 2 Extraction and analysis process of proteins from spermatozoa.
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its movement will be towards the positively charged
cathode. The protein’s molecular mass is then compared
to a standard ladder, which is loaded in a separate lane.
Upon staining, a visible spot indicates the presence of a
protein or possibly a multitude of proteins. Proteins can
be then identified through qualitative analysis.
Although 2D-E-based studies have generated great
insight on the overall nature and complexity of the
sperm proteome in terms of iso-electric point and mole-
cular mass, precise protein identification and characteri-
zation remains a challenge with this approach. 2D-PAGE
is a labor-intensive technique that is susceptible to gel
matrix irregularities due to experimental conditions such
as laboratory humidity, voltage fluctuations, and prepara-
tion slip-ups. Alternative methods can be used to circum-
vent these challenges: MS and two-dimensional
difference in gel electrophoresis (2D-DIGE).
Mass spectrometry
MS is an analytical tool that identifies proteins or pep-
tides by measuring the masses of molecules converted
into ions via their m/z ratio. It is even capable of deter-
mining the elemental composition of a molecule. In
addition, MS can be clinically useful in profiling biomar-
kers from tissues or bodily fluids as a method to diag-
nose different medical conditions.
Two of the most common MS techniques that have
been applied to study sperm proteins are MALDI-TOF
MS and LC-MS/MS. Both can account for systematic
biases when characterizing protein spots from a pre-
viously-run-electrophoresis gel. The spectral data
obtained from MS gives the protein’s m/z ratio and its
associated intensity, which aids in determining protein
differential expression and modifications.
With MALDI-TOF analysis, it is possible to determine
a protein’s m/z ratio by excising protein bands from the
gel and subsequently digesting them with trypsin. After
the peptide masses or peptide fingerprints have been
recorded, they can then be matched to sets of theoreti-
cally digested protein reference masses from a database
to identify the protein (peptide mass mapping).
On the other hand, LC-MS/MS is a highly sensitive
and specific analytical technique that combines the phy-
sical separation of peptides generated by trypsin diges-
tion of a spot by HPLC (high performance liquid
chromatography) followed by mass determination and
subsequent sequence in MS/MS set up. The use of
HPLC prior to MS has fueled tremendous growth in
proteomics over the past few years. Its initial application
for protein or peptide separation is based on the num-
ber of unique properties such as charge, hydrophobicity
and the presence of a specific tag or amino acid(s) [17].
The subsequent coupling to a tandem mass spectro-
meter with an interface allows for rapid separation and
identification of the complex protein mixtures and in
turn provides the primary peptide sequence of the origi-
nal complex protein.
Both 2D separation-based MALDI-TOF and LC-MS/
MS methods can be reproduced in laboratories and pro-
vide a 2D-map of the proteins in a complex mixture
based on their iso-electric point and molecular mass.
Since MALDI-TOF MS can be less sensitive and time
consuming, advancements in LC-MS/MS analysis pro-
vide an enhanced method for protein identification
throughput and a potential future diagnostic tool.
Nevertheless, MS is not perfect. “Noisy” data from
external interference may give false positive peaks, mak-
ing it difficult to detect protein changes, especially in
low-copy and low-abundance proteins. Alternatively,
tandem mass spectrometry (MS/MS) can be applied to
further fragment protein mixtures, and more impor-
tantly, to improve the detection limits of compounds
and the signal-to-noise ratio relative MS. However, the
total ion current of some compounds may be decreased
using MS/MS while also possibly affecting the efficiency,
reproducibility and detection of the mass spectra.
Difference in gel electrophoresis
DIGE is a type of gel electrophoresis used to detect
quantitative changes in protein abundance. This techni-
que has played an essential role in the advancement of
proteomics in that it takes the focus off the whole pro-
tein and places it onto its constituent peptides [19]. It is
at the protein level where most PTMs occur that cause
the significant variations in the three-dimensional pro-
tein structure and gel electrophoretic behavior. Thus, it
is the peptides that provide the best basis of proteomic
comparison [19]. DIGE can overcome 2D-E limitations
that are due to inter-gel variation by including an inter-
nal standard in each gel and also provide faster through-
put for subsequent analysis-since the proteins from the
different sample types are run on the same gel, they can
be directly compared. Therefore, this technique has the
potential to be used one day in a clinical setting to com-
pare samples of healthy and diseased states to formulate
a prognosis for future direction and treatment.
Bioinformatics
One of the most daunting challenges currently facing
proteomics is making sense of the vast data collected
thus far. Bioinformatics, which employs statistical analy-
sis and algorithms, can assist proteomic-based studies in
analyzing data and identifying proteins of interest from
MS or other technical data [24]. One system used by
bioinformatics is Gene Ontology (GO), which can reveal
meaningful patterns found in proteins [25]. A recent
study using fly models employed GO, leading to the
development of new ideas on gene regulation and chro-
matin organization [26]. Proteomics will expand on the
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current knowledge of human spermatozoa as bioinfor-
matics applications continue to be developed in the
future.
Future direction of techniques
Due to the complexity of proteomic samples, 1D separa-
tion techniques are no longer sufficient. Because PTMs
occur at the peptide level-and they are the main factors
that distinguish similar samples-additional multidimen-
sional separation techniques must be employed to
reduce a protein’s complex nature. Advances in chroma-
tographic columns based on restricted access materials
and monolithic columns have been suggested to
improve selectivity. In addition, stationary phases have
been introduced to improve the enrichment of low-
abundance proteins and their detection. Isotope-coded
affinity tag (ICAT) and isobaric tag for relative and
absolute quantification (iTRAQ) are recently developed
proteomic methods used to identify and quantify low-
abundance and low-concentration proteins. Neverthe-
less, advancements in MS must keep up with the fast-
developing multidimensional separation techniques to
achieve optimum resolution.
Furthermore, both consistent analysis of LC-MS/MS
and sample throughput have been a few of the key bot-
tlenecks for many proteomic studies [27]. LC-MS/MS
data requires multiple stages of analysis, and protein
separation often takes several hours to separate a single
sample. A proposed approach to improve sample
throughput is to develop faster scanning mass spectro-
meters. In order to overcome some of the most com-
mon challenges in the field, it is necessary to improve
the effectiveness of sample preparation to reduce the
protein’s complexity and to enrich the low abundance
proteins while decreasing the more abundant, less signif-
icant ones. Miniaturization and extensive data proces-
sing and analysis are also important.
Proteomics and mature spermatozoa
Until recently, most proteomic analysis of spermatozoa
was largely conducted utilizing the 2D-PAGE approach.
In terms of molecular mass and iso-electric point, 2D-E-
based studies have been valuable in generating data on
the overall nature and complexity of the sperm pro-
teome and the nature of some of those proteins targeted
by the human immune system. An advanced 2D-PAGE
resolution using narrow pH ranges for iso-electrofocus-
ing reported 3,872 different protein spots–16 proteins of
significance were identified [28].
Early sperm proteome analyses identified 1397 protein
spots–at least 98 surface-related–and were catalogued
by means of 2D-PAGE analysis [29]. An in vitro experi-
ment conducted with prolactin, one of the tryrosine
kinase surface receptors, demonstrated improved fertiliz-
ing potential of mammalian spermatozoa after the
addition of the hormone [30]. Earlier studies have noted
insulin to be a hormone of interest from its displayed
interaction with both the plasma membrane and sperm
acrosome [31]. Moreover, these reports further rein-
forced the essential role of surface receptors during fer-
tilization, and any defect or abnormality may result in
suboptimal reproductive potential or even infertility.
Additional proteomic analysis at the basal level of the
sperm’s surface can provide additional knowledge and
insight into the possible biological mechanistic processes
involved in acrosome reaction, capacitation, and ulti-
mately, fertilization.
Furthermore, several proteomic studies (Refer to
Table 1) have uncovered numerous housekeeping sperm
proteins involved in fundamental processes such as oxi-
dative phosphorylation and glycolysis [28,29,32-40]. Ait-
ken et al. (1998) discussed the indispensable role of
NADPH oxidases in sperm capacitation to help drive
cAMP-induced tyrosine phoshorylation signal transduc-
tion cascades through possible suppression of tyrosine
phosphatase activity [41]. Inhibiting protein kinase A
(PKA) phosphorylation of A-kinase anchor proteins
(AKAPs) revealed hyperactivation impairment, resulting
in suboptimal reproductive function and subsequent
infertility [38,41-43]. Human spermatozoa have been
found to contain all the machinery necessary to sustain
a cAMP-signaling pathway in the sperm tail and the
components associated with the 26S proteasome
[29,37,44]. The 26S proteasome is an ATP-dependent
proteolytic complex essential in the sperm-egg interac-
tion [29,37,44]. Indeed, past proteomic studies hold for
a promising future of discovering new sperm proteins,
which in turn will allow researchers and clinicians to
better understand and diagnose sperm dysfunction (See
Figure 3).
Comparative studies employing proteomic techniques
have also helped to identify proteins of interest in infer-
tile men in comparison to fertile men. Several compara-
tive studies have recently been completed, most notably
a 2007 study performed by Zhao et al. [45]. The study
compared 8 men with asthenozoospermia with healthy
controls. The authors identified 10 of 17 proteins with
either increased or decreased frequency in the astheno-
zoospermic samples. They were able to link these differ-
ences to enzymes involved in sperm metabolism. Such
comparative studies are expected to identify biomarkers,
which will aid clinicians in better diagnosing male-factor
infertility.
Proteomic approaches are now focused on characteriz-
ing the tyrosine phosphorylated proteins to better
understand and clarify the mechanistic processes behind
the capacitation-dependent alternations involved in
sperm function. In the future, with improvements in
proteomic methods, it will be possible to generate an
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accurate proteomic profile of normal human spermato-
zoa, which can aid in understanding and differentiating
between the various functional stages of sperm cells
(e.g., mature versus immature, capacitated versus unca-
pacitated, and normal versus defective parameters).
With this information, it would be possible to verify
whether impaired sperm function is related to PTMs
involved in generating normal functional spermatozoa.
Further understanding of various physiological and bio-
chemical changes in post-testicular sperm maturation
will unravel the molecular basis of defective sperm func-
tion characterized in subfertile men.
A study by Shetty et al. identified several novel sperm
protein sequences from a 2D-E gel [39]. Many of those
detected shared identical sequences, further stressing
the importance of PTMs to sperm proteins. Another
detailed MALDI-TOF analysis of the human sperm pro-
teome consisting of over 100 mapped spots on 2D gels
by Martinez-Heredia et al. identified 98 different pro-
teins, and 23% of them had yet to be recorded on the
human spermatozoa [36]. In addition, proteomics is a
continuously evolving field and researchers are con-
stantly exploring new avenues to further define and
characterize the human proteome. The recent applica-
tion of a highly sensitive nanoscale liquid chromatogra-
phy technique combined with MS identification yielded
1056 gene products, 8% of which had not been pre-
viously characterized [29].
Clinical applications of proteomics
Although proteomics has only been used to study human
spermatozoa in the laboratory setting, proteomic-based
studies may one day be used in the clinical setting to
identify sperm dysfunction. Sperm chromatin, which
consists of DNA and proteins, is essential for proper
sperm function and embryonic development, as several
studies have linked defects in sperm chromatin to poten-
tial reproductive errors [46-48]. Proteomics offers the
potential for expanding on clinical diagnostic testing of
sperm for infertility, which is currently limited to count,
motility and morphology.
In order to apply proteomics to a clinical setting, several
areas of study must be expanded upon. The first milestone
that must be reached in order to better understand human
spermatozoa is to determine the entire human sperm pro-
teome. While a study by Baker and colleagues identified
1056 proteins and a more recent study by Li and collea-
gues identified 3872 spots, very little is known about the
sperm proteome [28,29]. Prior studies have already been
conducted on seminal plasma. Therefore, once more stu-
dies are completed, a better understanding of human eja-
culate will be gained [49]. Future proteomics studies will
allow for a better understanding of PTMs such as phoso-
phorylation and sperm capacitation [38,50]. These PTMs
are vital for consequent stages of sperm formation,
maturation and activation [51]. Currently, there is a very
limited understanding of these modifications, but this area
of study is continuing to expand in scope with the pending
publication of new studies.
A second milestone is the publication of comprehen-
sive comparative studies between normal spermatozoa
and abnormal spermatozoa. Such studies will highlight
the potential of proteomics to identify biomarkers that
can, in turn, help clinicians pinpoint certain peptides or
Table 1 Proteomic studies on mature human spermatozoa
Authors Study Proteomic
Technique
Outcome
Johnston et al. 2005 [37] First extensive analysis of human sperm proteome LC-MS/MS 1760 proteins
identified
Martinez-Heredia et al. 2006 [36] de Mateo
et al. 2007 [40]
Goal to provide a reference 2D map of the mature human
sperm proteome
MALDI-TOF 131 proteins
identified
Ficarro et al. 2003 [38] Phosphoproteome analysis of capacitated human sperm LC-MS/MS 60 proteins
identified
Domagala et al. 2007 [32] Identification of sperm immunogenic antigens LC-MS 35 proteins
identified
Secciani et al. 2009 [33] Protein profile of capacitated versus ejaculated human
sperm
MS/MS 116 proteins
identified
Shetty et al. 2001 [39] Identification of immunocontraceptive candidates MALDI-MS 8 proteins
identified
Bohring et al. 2001 [34] Isolation and identification of sperm membrane antigens MALDI-MS 18 proteins
identified
Baker et al. 2007 [29] Identification of proteins in human sperm using LC-MS/MS
analysis
LC-MS/MS 1056 proteins
identified
Lefievre et al. 2007 [35] Identify targets for S-nitrosylation in human sperm LC-MS/MS 240 proteins
identified
Li et al. 2007 [28] Establish high-resolution 2-D map of human sperm proteins MALDI-MS 16 proteins
identified
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metabolites that may be linked to male infertility.
Furthermore, proteomics can be employed in compara-
tive studies between human sperm samples and model
organisms such as mice, fish, worms, flies, and sea urch-
ins, all of which have already contributed to greater
understanding of human spermatozoa [5,52].
Protamines present a starting point for proteomic stu-
dies to identify proteins with altered expression in infer-
tile patients. For example, one recent study by de Mateo
and colleagues found an altered ratio of two protamine
proteins-protamine 1 and protamine 2, also known as
P1 and P2, respectively [40]. In addition, proteomic
Figure 3 Human sperm and its formation and associated processes.
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studies using mouse models have identified the chaper-
one protein HSPA2 as an important assessment factor
for infertility in humans [5]. One study using astheno-
zoospermic patients identified HSPA2 as one of 17 pro-
teins with abnormal levels in comparison to samples
from normal donors [53]. Since HSPA2 is believed to be
vital to several sperm processes such as plasma mem-
brane remodeling and cytoplasmic extrusion, HSPA2
resembles a biomarker that can aid in clinical diagnosis
of male infertility (e.g., less or absent sperm-specific pro-
teins may correspond to incompletely formed or defec-
tive sperm chromatin) [54].
Studies such as these can produce vast amounts of
data, but with the help of bioinformatics applications,
researchers can discover meaningful patterns that may
be applied in a clinical setting [55]. Furthermore, similar
proteomic studies may identify additional biomarkers
that are indicative of male-factor infertility signaling
pathways.
Factors affecting proteomic studies
Several factors affect proteomics, all of which must be
taken into account when putting proteomics into prac-
tice in the clinical setting. The 2D-PAGE technique is
laborious and indefinite in identifying and characterizing
proteins [5]. In a study by Li et al., only 16 of 3872
spots were identified using this technique, while in simi-
lar experiment conducted by Martinez-Heredia et al.,
only 98 of 1000 spots were identified [28,53].
Variations in study findings can be attributed to
numerous factors, many of which are uncontrollable in
current proteomic advances. Pre-analytical variables may
affect the testing for biomarkers during sample collec-
tion, pipetting, and dilution [55]. Human biological var-
iation with age, race, nutrition, life style, stress,
environment or global location of the sample population
may also affect experimental results [56].
Nevertheless, biomarker discovery remains a very chal-
lenging task due to the complexity of the sample as well
as the wide dynamic range of protein concentrations
[24]. As the field of proteomics emerges to face several
challenges, bioinformatics can provide statistical support
in analyzing the vast amounts of data resulting from
proteomics testing. Although proteomics is an emerging
field facing many challenges, bioinformatics can provide
statistical support in analyzing the vast amounts of data
resulting from proteomics testing. However, it is
expected that the future proteomics studies may lead to
the development of novel diagnostic tools and therapeu-
tic drugs to improve sperm dysfunction by elucidating
potential causes of sperm impairment and providing
insights to its underlying mechanistic pathway [50].
Conclusion
As researchers and scientists note the sudden decline in
male reproductive potential worldwide, many have
focused their attention on male-factor defects. Several
reports have linked suboptimal sperm quality to this
growing concern [57,58]. Although much remains
unknown about human spermatozoa and its pathological
and physiological effects on reproductive function, recent
advances in proteomic techniques have provided insight
into sperm function and dysfunction. Several multidi-
mensional separation methods have been utilized to iden-
tify and characterize spermatozoa [28,29,37]. Future
developments in bioinformatics can further assist
researchers in understanding the vast amount of data col-
lected in proteomic studies. In addition, such advances in
proteomics may help to decipher metabolites directly
involved in normal growth, development, and reproduc-
tion, which can stand as biomarkers in the detection of
disease or sperm impairments. Multinuclear nuclear
magnetic resonance-based metabolomic approaches
along with advanced proteomic techniques may provide
essential information of the cellular metabolome in order
to further understand cellular function. With the identifi-
cation of novel biomarkers through proteomic studies,
clinical tests and treatments for sperm dysfunction might
be developed to potentially help infertile couples.
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